Technical Analysis for IBRX - ImmunityBio, Inc.

Grade Last Price % Change Price Change
B 5.23 1.95% 0.10
IBRX closed up 1.95 percent on Monday, March 18, 2024, on 82 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
Wide Bands Range Expansion 0.00%
Pocket Pivot Bullish Swing Setup 1.95%
Wide Bands Range Expansion 1.95%
Gapped Up Strength 1.95%
MACD Bearish Signal Line Cross Bearish 6.52%
Wide Bands Range Expansion 6.52%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.95%
Wide Bands Range Expansion 2.95%
Overbought Stochastic Strength 2.95%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 17 hours ago
Fell Below 10 DMA about 17 hours ago
Down 2 % about 18 hours ago
Down 1% about 18 hours ago
10 DMA Support about 19 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ImmunityBio, Inc. Description

NantKwest (NASDAQ: NK) is an innovative, clinical-stage, immunotherapy company focused on harnessing the power of the innate immune system to treat cancer and infectious diseases. NantKwest is the leading producer of clinical dose forms of off-the-shelf natural killer (NK) cell therapies. The activated NK cell platform is designed to destroy cancer and virally-infected cells. The safety of these optimized, activated NK cells-as well as their activity against a broad range of cancers-has been tested in phase I clinical trials in Canada and Europe, as well as in multiple phase I and II clinical trials in the United States. By leveraging an integrated and extensive genomics and transcriptomics discovery and development engine, together with a pipeline of multiple, clinical-stage, immuno-oncology programs, NantKwest's goal is to transform medicine by bringing novel NK cell-based therapies to routine clinical care. NantKwest is a member of the NantWorks ecosystem of companies.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Immune System Immunotherapy Infectious Diseases Cancer Treatment Cancer Immunotherapy Genomics Virotherapy Natural Killer Cell Lymphocytes Pelareorep

Is IBRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.93
52 Week Low 1.25
Average Volume 3,939,751
200-Day Moving Average 3.07
50-Day Moving Average 4.33
20-Day Moving Average 4.85
10-Day Moving Average 5.10
Average True Range 0.44
RSI (14) 57.26
ADX 14.14
+DI 19.64
-DI 15.00
Chandelier Exit (Long, 3 ATRs) 4.22
Chandelier Exit (Short, 3 ATRs) 4.70
Upper Bollinger Bands 5.70
Lower Bollinger Band 4.00
Percent B (%b) 0.72
BandWidth 35.00
MACD Line 0.23
MACD Signal Line 0.23
MACD Histogram 0.0009
Fundamentals Value
Market Cap 3.51 Billion
Num Shares 670 Million
EPS -1.04
Price-to-Earnings (P/E) Ratio -5.03
Price-to-Sales 5684.55
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.76
Resistance 3 (R3) 5.75 5.56 5.67
Resistance 2 (R2) 5.56 5.42 5.57 5.64
Resistance 1 (R1) 5.39 5.34 5.48 5.41 5.61
Pivot Point 5.20 5.20 5.25 5.21 5.20
Support 1 (S1) 5.04 5.07 5.12 5.05 4.85
Support 2 (S2) 4.85 4.99 4.86 4.82
Support 3 (S3) 4.69 4.85 4.79
Support 4 (S4) 4.70